26 research outputs found
Getting an insight in the determinants of new product introductions of US biopharmaceutical start-ups
The blurring boundaries of research: towards a property rights explanation of knowledge transfer in biotechnology
This paper investigates how the different mechanisms for knowledge transfer are linked to the underlying technological life cycle. Following the most recent developments in the organizational economics literature, we analyze knowledge transfer from an incentive point of view. We modified the basic version of the incomplete contracts model (or property rights model) to include knowledge as an asset. The empirical hypotheses which can be derived from this model are contrasted to other streams of thought such as organizational ecology. Using this comparison as a guideline, we undertake a first empirical test of this property rights model in two technological subfields of biotechnology: monoclonal antibodies and protein engineering. The results, though tentative, are challenging: the property rights model clearly adds to our insights in spin-offs as a mechanism for knowledge transfer and in the incentive factors that influence an organization's decision to enter a technological collaboration with a university or another biotech firm.info:eu-repo/semantics/publishe
The blurring boundaries of research: towards a property rights explanation of knowledge transfer in biotechnology
This paper investigates how the different mechanisms for knowledge transfer are linked to the underlying technological life cycle. Following the most recent developments in the organizational economics literature, we analyze knowledge transfer from an incentive point of view. We modified the basic version of the incomplete contracts model (or property rights model) to include knowledge as an asset. The empirical hypotheses which can be derived from this model are contrasted to other streams of thought such as organizational ecology. Using this comparison as a guideline, we undertake a first empirical test of this property rights model in two technological subfields of biotechnology: monoclonal antibodies and protein engineering. The results, though tentative, are challenging: the property rights model clearly adds to our insights in spin-offs as a mechanism for knowledge transfer and in the incentive factors that influence an organization's decision to enter a technological collaboration with a university or another biotech firm.
t(9;12)(q22;p13) ETV6::SYK: A new recurrent cytogenetic aberration and tyrosine kinase gene fusion in myeloid or lymphoid neoplasms associated with eosinophilia.
The determinants of the patenting behavior of European Universities
info:eu-repo/semantics/publishe
Antecedents of Patenting Activity of European Universities
This paper analyzes antecedents of patent activity of 87 European universities. The findings reveal that more patent activity is observed within larger universities and at universities that encompass engineering and biomedical departments. Higher levels of scientific productivity and contract research coincide with higher levels of patent activity. The findings reveal that academic patenting is contingent on the combined effect of a scientific and entrepreneurial orientation of universities.info:eu-repo/semantics/publishe
Scientific and entrepreneurial effectiveness of european universities: an empirical assessment
info:eu-repo/semantics/nonPublishe